Meditation retreat rapidly reprograms body and mind
Researchers at the University of California San Diego have found that an intensive retreat combining multiple mind-body techniques, including meditation and healing practices, produced rapid and wide-ranging changes in brain…
AI-powered diabetes prevention program shows similar benefits to those led by people
Researchers from Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health report that an AI-powered lifestyle intervention app for prediabetes reduced the risk of diabetes similarly to…
A new tool to find hidden ‘zombie cells’
When it comes to treating disease, one promising avenue is addressing the presence of senescent cells. These cells — also known as “zombie cells” — stop dividing but don’t die…
Pregnant patients with preexisting high cholesterol may have elevated CV risk
Preexisting hyperlipidemia in pregnancy is associated with heightened risks of obstetric complications and early cardiovascular events in the first five-years postpartum, according to a new study being presented at ACC’s…
Counting bites with AI might one day help prevent childhood obesity
The faster a child takes bites during a meal or snack, the greater risk they have for developing obesity, according to researchers in the Penn State Department of Nutritional Sciences.…
AI analysis of world’s largest heart attack datasets opens way to new treatment strategies
A landmark international study led by the University of Zurich has shown that artificial intelligence can assess patient risk for the most common type of heart attack more accurately than…
How old are you really? Researchers find a new way to measure biological age
How old are you really? Researchers find a new way to measure biological age Researchers from Edith Cowan University (ECU) have developed an innovative new way to measure biological age,…
Where you live may affect your brain health, new study finds
The conditions where you live may influence your brain health and risk for dementia, according to a new study from Wake Forest University School of Medicine The study, published today…
Could reducing inflammation help combat fatigue in people with early-stage breast cancer?
New research reveals that inflammatory responses may play a role in different types of fatigue experienced by many people with cancer. The findings are published by Wiley online in CANCER,…
FDA approves PharmaMar’s Zepzelca® (lurbinectedin) and Atezolizumab (Tecentriq®) Combination as First-line Maintenance Therapy for Extensive-stage Small Cell Lung Cancer
harmaMar (MSE:PHM) has announced that the U.S Food and Drug Administration (FDA) has granted approval for Zepzelca® (lurbinectedin) in combination with atezolizumab (Tecentriq®) as a maintenance treatment for adults with…